We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Improving Brain Cell Survival After Trauma

By HospiMedica staff writers
Posted on 14 Aug 2006
A new study has discovered a protein in the brain that can save neurons from dying after experiencing traumatic brain injury from incidents such as stroke, car accidents, and falls. More...


Researchers from the Howard Florey Institute at the University of Melbourne (Australia) discovered that this naturally occurring protein, called BP5, is produced more than usual in brain cells after they have experienced traumatic injury. The researchers used serial analysis of gene expression (SAGE) to identify 50,000 sequence tags, representing 18,000 expressed genes in the cortex two hours after traumatic brain injury.

The SAGE data were validated on mice, and were confirmed for a subset of genes using in situ hybridization and immunocytochemistry on brain sections. While the majority of the genes examined showed a downward trend in expression over time, overexpression of BP5 in cultured cortical neurons increased the number of surviving neurons after gene transfection and growth factor starvation, compared with the control transfections. The study was published in the July 5, 2006, issue of the Journal of Neuroscience.

"BP5 works by using the cell's waste disposal system to flush away toxic and damaged proteins produced after injury, which appears to tip the balance towards nerve cell survival, instead of death,” said lead author Professor Seong-Seng Tan. "BP5's pattern of expression indicates that it allows neurons to survive in a stressed environment.”

The research is the first to show that this mechanism can be fruitfully manipulated to prevent brain cells from dying. The next challenge, the researchers say, is to understand how BP5 performs it neuron-saving function and develop drugs that can do the same thing, so they can help to save as many neurons as possible in patients suffering brain injury. Such a drug would limit damage to the brain right after the injury, as well as the subsequent few days when injured nerves release "suicide factors” that cause surrounding healthy neurons to die en masse.



Related Links:
Howard Florey Institute

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.